Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 8Melanoma 6Colonic Neoplasms 4Rectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Thyroid Neoplasms 1Solid Tumors 1Skin Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasms 1Lymphatic Metastasis 1Leukemia, Hairy Cell 1Hereditary Sensory and Autonomic Neuropathies 1Gastrointestinal Neoplasms 1Disease Progression 1Digestive System Neoplasms 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

AZD 6244 7trametinib 4mirdametinib 2fludarabine 2Inhalation 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1omipalisib 1lorlatinib 1fludarabine phosphate 1encorafenib 1dabrafenib 1binimetinib 1abemaciclib 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Radiation 1N-monoacetylcystine 1Melphalan 1Magnetic Resonance Spectroscopy 1Levetiracetam 1Lasers, Solid-State 1Lasers 1Injections 1Deoxycholic Acid 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × encorafenib × 90 days × Clear all
NCT04800822 2026-06-04

PF-07284892 in Participants With Advanced Solid Tumors

Pfizer

Phase 1 Terminated
53 enrolled
CNSGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neurofibromatosis 1, Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡